Overview

HD10 for Early Stages

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to find the optimum radiation dose and number of cycles for an ABVD chemotherapy combined with an involved field irradiation. It is to be tested whether the reduction from 4 to 2 cycles of ABVD and/or the reduction of the radiation dose from 30 to 20 Gy is feasible without a loss of efficacy.
Phase:
Phase 3
Details
Lead Sponsor:
University of Cologne
Treatments:
Bleomycin
Doxorubicin
Liposomal doxorubicin
Vinblastine